RxDoctor Payments DataLook up a doctor →

Girish Kunapareddy, MD

Internal Medicine · Terre Haute, INNPI 1457646135

Payments from drug & device makers

$329,328in general payments, 2019–2025

Across 1,431 payments — averaging $230.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$117K
  • E.r. Squibb & Sons, L.L.C.$63K
  • AstraZeneca$33K
  • Incyte Corporation$17K
  • Astellas Pharma US Inc$16K
  • Pfizer$16K
  • plus $68K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.151$116,579
E.r. Squibb & Sons, L.L.C.105$63,014
AstraZeneca(2 entities)118$32,872
Incyte Corporation48$17,234
Astellas Pharma US Inc39$15,696
Pfizer81$15,691
Genentech USA, Inc.53$9,180
Sun Pharmaceutical Industries Inc.16$8,987
Johnson & Johnson(2 entities)71$6,202
Bristol Myers Squibb56$5,166
Shield Therapeutics Inc7$5,001
Novartis97$4,934
Seagen Inc.45$4,764
Gilead(2 entities)25$4,023
Janssen Scientific Affairs, LLC6$2,468
Morphosys, US Inc.6$1,513
GSK16$1,454
Merck59$1,272
Sanofi37$1,171
AbbVie26$1,119
Lilly USA, LLC35$1,042
Daiichi Sankyo Inc.27$899
Amgen34$759
Pharmacyclics LLC, An Abbvie Company21$736
Adaptive Biotechnologies Corporation8$483
Regeneron Healthcare Solutions, Inc.9$459
TG Therapeutics, Inc.1$397
Rigel Pharmaceuticals, Inc.10$397
Beigene USA, Inc.11$355
Takeda Pharmaceuticals U.S.A., Inc.14$342
Jazz Pharmaceuticals Inc.11$338
Array Biopharma Inc18$301
Exelixis Inc.11$260
Bayer9$248
ADC Therapeutics America, Inc.3$227
Boehringer Ingelheim12$204
Sobi, Inc8$189
Pharmacosmos Therapeutics Inc.8$188
Beone Medicines USA, Inc.4$171
G1 Therapeutics, Inc.4$170
Servier Pharmaceuticals LLC9$158
Eagle Pharmaceuticals, Inc.1$149
AVEO Pharmaceuticals, Inc.3$139
Genmab U.S., Inc.8$137
Abbott1$123
Puma Biotechnology, Inc.6$118
Epizyme, Inc.2$115
Sirtex Medical Inc1$114
Acrotech Biopharma Inc.6$113
Gamida Cell Inc.1$107
Tempus AI, Inc1$103
Pharmaessentia USA Corporation5$101
Coherus Oncology, Inc.4$97
Genentech, Inc.1$96
Clovis Oncology, Inc.5$88
EUSA Pharma (US) LLC4$84
Foundation Medicine, Inc.5$81
Dova Pharmaceuticals4$76
Syndax Pharmaceuticals, Inc.3$75
Karyopharm Therapeutics Inc.4$67

How this compares

$329,328 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$223,032
Medicare patients
606
Services billed
2,415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Terre Haute

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →